Charlotte's Web Holdings, INC 8-K filings

Charlottes Web Holdings, Inc. announced second quarter 2026 results, highlighting a strengthened balance sheet through debenture conversion, expanded gross margins, and reduced operating cash use, alongside positive federal hemp policy developments.

Co-founder Jared Stanley has resigned from the Charlotte's Web Board of Directors to focus on his role as CEO of clinical-stage pharmaceutical venture DeFloria, Inc.

Charlottes Web Holdings, Inc. announced the closing of a significant investment by British American Tobacco's subsidiary, BT DE Investments Inc., involving a new equity purchase and the conversion of a convertible debenture.

Charlotte's Web Holdings, Inc. has successfully closed a major debt-to-equity conversion and private placement with British American Tobacco, strengthening its balance sheet.

Charlottes Web announced Q1 2026 results, highlighting progress on a transformative transaction with BAT, the activation of a CMS healthcare access pathway, and continued improvement in Adjusted EBITDA.

Charlotte's Web Holdings, Inc. announced a C$103 million equity commitment from British American Tobacco, significantly increasing BAT's ownership to approximately 40.8% through a new investment and debenture conversion.

Charlotte's Web announced its Q4 and full-year 2025 financial results, highlighted by a strategic transaction with BAT and participation in a new CMMI Medicare pilot program.

Charlotte's Web Holdings, Inc. announced a transaction with British American Tobacco subsidiary BT DE Investments, Inc., converting a C$75.3 million debenture to equity and securing an additional US$10 million equity investment, totaling approximately US$75 million.

Charlotte's Web reports Q3 2025 results, showing revenue decline but significant cost reductions and a strategic pivot towards medical channels and in-house manufacturing.

Charlotte's Web Holdings, Inc. announced the appointment of Borgia Walker, a British American Tobacco designee, to its board of directors, following Jonathan Atwood's resignation.

Jonathan Atwood will resign from the Board of Directors of Charlotte's Web Holdings, Inc. effective October 1, 2025, with no reported disagreements.

Charlotte's Web Holdings, Inc. filed an amended 8-K to correct a scrivener's error regarding the appointed auditor and confirm shareholder votes from its June 12, 2025 annual meeting.

Charlotte's Web Holdings, Inc. announced its second consecutive quarter of year-over-year revenue growth for Q2 2025, driven by new product innovations and significant cost reductions.

Charlotte's Web Holdings, Inc. announced the departure of its Senior Vice President, General Counsel, and Corporate Secretary, Stephen Rogers, with Chief People Officer Mindy Garrison assuming the Corporate Secretary role.

Charlottes Web Holdings, Inc. has provided a $750,000 promissory note to its joint venture, DeFloria Inc., with an initial interest rate of 13.25% and a maturity date tied to either December 31, 2026, or a future capital raise by DeFloria.

Charlotte's Web Holdings, Inc. announced the successful ratification of all proposals, including the election of six directors and the appointment of Ernst & Young LLP as auditors, at its 2025 annual general meeting of shareholders.

Charlotte's Web Holdings, Inc. announced its Q1 2025 results, marking its first year-over-year revenue increase in over three years, driven by e-commerce growth and strategic initiatives.

Charlotte's Web reports sequential quarterly revenue growth and significant cost reductions for 2024, positioning the company for sustained growth in 2025.

Charlotte's Web announces that DeFloria, Inc., a collaborative entity, has received FDA approval to proceed with Phase 2 clinical trials for AJA001, a botanical pharmaceutical candidate for autism spectrum disorder (ASD).

Charlottes Web Holdings reports the resignation of its Principal Accounting Officer, Sarah Cambridge, and the immediate appointment of Chief Financial Officer, Erika Lind, to the role.

Charlotte's Web reported a return to quarter-over-quarter growth in Q3 2024, driven by new product launches and expanded retail partnerships.

Charlotte's Web Holdings, Inc. has entered into a retention agreement with its Chief Financial Officer, Erika Lind, providing a $100,000 incentive paid over four quarters.

Charlotte's Web is opposing new California regulations that restrict the sale of many ingestible full-spectrum hemp CBD products, despite them meeting federal requirements.

Charlotte's Web Holdings has changed its independent auditor from Ernst & Young to PKF O'Connor Davies, effective August 21, 2024.

Charlotte's Web reported a decrease in revenue for the second quarter of 2024, but also launched a new e-commerce platform and implemented cost-cutting measures.

Charlotte's Web has announced the appointment of Erika Lind as its new Chief Financial Officer, effective June 29, 2024, succeeding Jessica Saxton.

Charlotte's Web reports the results of its 2024 annual general meeting, including the election of directors and the appointment of two new board members.

Charlotte's Web reported a decrease in revenue for Q1 2024, while making progress on its True North turnaround initiatives, including a new e-commerce platform launch and cost-cutting measures.

Charlotte's Web will hold its Annual General and Special Meeting of Shareholders on June 13, 2024, featuring proposed changes to the Board of Directors.

Charlotte's Web reported its 2023 fourth quarter and year-end financial results, highlighting a company-wide turnaround initiative called True North aimed at enhancing the consumer journey and driving sustainable growth.